尤其是糖尿病. 腎病變,自CREDENCE(Canagliflozin on Renal and Cardiovascular Outcomes in Participants. With Diabetic Nephropathy)研究之後,確立了. SGLT-2i在腎臟保護 ...
確定! 回上一頁